News
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
15h
MarketBeat on MSNWith Novo Nordisk's CEO Out, Wall Street Wants an American LeaderCompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
The European Medicines Agency warns that Novo Nordisk's Ozempic and Wegovy may, in rare cases, cause NAION—a serious eye condition that can lead to vision loss. The EMA has asked the company to update ...
Eli Lilly's (LLY) sees a 60% sales jump from April to May in India for its obesity/ diabetes drug Mounjaro. Read more here.
Wall Street surged as the S&P 500 reclaimed 6,000, fueled by a strong jobs report. Discover market movers like Tesla, Moderna, and Procter & Gamble.
18h
Best Life on MSNOzempic Users Face 2x Higher Risk of Permanent Vision Loss, Researchers WarnOzempic and other GLP-1 drugs have forever altered the way people view, manage, and speak about obesity. However, it’s ...
The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results